Business
Cyber Kiosk Solutions, Inc. Grows Strategic Advisory Committee Focused on Expansion
Cyber Kiosk Solutions, Inc. Grows Strategic Advisory Committee Focused on Expansion.
About this update from Moon Equity Hldgs Corp.
[{"type":"text","content":"\n\n\n\nCyber Kiosk Solutions, Inc. Grows Strategic Advisory Committee Focused on Expansion\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nCyber Kiosk Solutions, Inc. Grows Strategic Advisory Committee Focused on Expansion\nDMH International President and CEO, Rik J. Deitsch, Joins Committee\nPR Newswire\nCORAL SPRINGS, Fla., April 17, 2014\n\n\n\nCORAL SPRINGS, Fla., April 17, 2014 /PRNewswire/ -- Cyber Kiosk Solutions, Inc. (OTC Pink: CYBK), hereafter referred to as the \"Company\" or \"CYBK\" is pleased to announce that the Company has added DMH International President and CEO, Rik J. Deitsch, to its new Strategic Advisory Committee, formed to help navigate CYBK's expansion into several business verticals. The Company recently named Steven Machat, the head of LegalizePot.us, Inc., the first member of the committee. \n\nRik Deitsch, President and Chief Executive Officer, DMH International, (OTCQB: DMHI) has many years of entrepreneurial and executive management experience in health and life sciences companies. He founded Touch Medical Solutions (the operating Division of DMH International) in 2010 and has been the Chairman of the Board, President and CEO of the Company since December 31, 2012. From November 2002 through the present, Mr. Deitsch has served as the Chief Executive Officer of Nutra Pharma Corporation, a public biotechnology company with therapies for the treatment of Multiple Sclerosis, HIV and pain. Nutra Pharma markets OTC analgesics under the brand name Nyloxin. From February 1998 through November 2002, Mr. Deitsch served as the President of NDA Consulting Inc., a biotechnology research group that provided consulting services to the pharmaceutical industry. NDA Consulting specialized in the research of peptides derived from Cone Snail venom, Cobra venom and Gila Monster venom. \n\nMr. Deitsch holds both a B.S. in Chemistry and an M.S. in Biochemistry from Florida Atlantic University and has conducted clinical and laboratory research in collaboration with scientists at Duke University Medical Center and the Cleveland Clinic. Mr. Deitsch has served ...